Urinary Chemiluminescence-an Evaluation of its Use in Clinical Practice
- 1 December 1984
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 56 (6) , 650-654
- https://doi.org/10.1111/j.1464-410x.1984.tb06138.x
Abstract
A substance, as yet unidentified, is excreted in the urine and acts as a chemical carcinogen. This substance during oxidative reactions will exhibit urinary chemiluminescence (UCL) and it is this release of energy in the form of light which activates the intracellular changes responsible for carcinogenesis. People (177) 110 patients being followed up endoscopically for transitional cell carcinoma of the bladder (TCCB) and 67 controls, had their UCL measured. The UCL estimations confirmed previously reported trends where those with active disease had the highest UCL (84) and the controls had the lowest (55). These results did not reach statistical significance and the wide variations of the results do not allow UCL, as yet, to be of practical clinical use.This publication has 7 references indexed in Scilit:
- Observations on Urinary Chemiluminescence of Normal Smokers and Non-smokers and of Patients with Bladder CancerBritish Journal of Urology, 1973
- Bladder tumours and smokingInternational Journal of Cancer, 1970
- Studies in the Etiology and Prevention of Bladder CarcinomaJournal of Urology, 1969
- Results of a French Survey on the Role of Tobacco, Particularly Inhalation, in Different Cancer SitesJNCI Journal of the National Cancer Institute, 1961
- The Association of Smoking with Cancer of the Urinary Bladder in HumansArchives of internal medicine (1960), 1956
- Physico-Chemical Aspects of Chemical CarcinogensNature, 1947